# BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

> **NCT00603902** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 4008 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Lorcaserin 10 mg once daily (QD)
- **DRUG:** Lorcaserin 10 mg twice a day (BID)
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT00603902
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 4008 (ACTUAL)
- **Last updated:** 2019-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603902, "BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00603902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*